Gamow Labs builds frontier AI systems to interpret the human genome.

We run experiments in our robotic wet lab in Boulder, Colorado.

Research

All research
  1. LabBench: Can AI agents decide what experiment to run next?

    Accelerating biological experimentation relies on quickly deciding which experiment comes next. Frontier agents interpret lab data well but rarely choose the right next experiment.

  2. Cohort-scale variant reanalysis with agentic AI: GEMINI and SouthSeq

    When a variant classification happens on someone’s genome, it’s a snapshot of what was knowable that day. Obviously with time, the evidence underneath it keeps moving.

  3. Gamow Labs’ submission to the Rare Disease, Real Kid: The MVA Hackathon 2026

    Yesterday, HuggingFace – in collaboration with the MVA Society, SageBionetworks, BEACON, Anthropic, and Amazon Web Services (AWS) – announced a hackathon aimed at finding answers for a child living with Mosaic Variegated Aneuploidy (MVA).

First clinical study: outperformed clinical labs.

In a blinded analysis of 66 alveolar capillary dysplasia cases called non-diagnostic by a number of clinical labs, Gamow Labs successfully identified a molecular explanation for all known cases and even solved two that had evaded human resolution for years (manuscript in review).

66 non-diagnostic cases re-analyzed in a blinded study
100% of known cases given a molecular explanation
2 cases solved that had eluded experts for years

More access to genome interpretation means better care.

43% of 178 infants diagnosed in California's Project Baby Bear, saving $2.5M
$2.9M net ROI from Florida's Project Baby Manatee
214 hospital days cut by Michigan's Project Baby Deer

H.R. 7118, introduced January 2026, would extend Medicaid coverage for children's genome sequencing nationwide.

We push frontier models to their limits in genomics and experimental biology.